4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001576885-25-000011
CFO & Chief Business Officer sold 13,235 shares at $1.84 ($24,367)
- CFO & Chief Business Officer acquired 66,800 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zuga Matt CFO & Chief Business Officer | 2025-01-03 | Sale 10b5-1 | −13,235 | $1.84 | $24,367 | 198,210 | D |
| Zuga Matt CFO & Chief Business Officer | 2025-01-06 | Grant or award 10b5-1 | +66,800 | 265,010 | D | ||
| Derivatives | |||||||
| Zuga Matt CFO & Chief Business Officer | 2025-01-06 | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +100,300 | 100,300 | D | ||
| Open-market sales · 13,235 sh · avg $1.84 · $24,367 | |||||||
Loading xslF345X05/wk-form4_1736297601.xml…